Exicure, Inc. (XCUR)
1.23
-0.06
(-4.65%)
USD |
NASDAQ |
Sep 03, 16:00
1.26
+0.03
(+2.44%)
After-Hours: 20:00
Exicure Research and Development Expense (TTM) : 2.029M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.029M |
| March 31, 2026 | 2.79M |
| December 31, 2025 | 3.286M |
| September 30, 2025 | 2.631M |
| June 30, 2025 | 1.743M |
| March 31, 2025 | 0.808M |
| December 31, 2024 | 0.00 |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | 1.607M |
| June 30, 2023 | 5.948M |
| March 31, 2023 | 12.23M |
| December 31, 2022 | 18.08M |
| September 30, 2022 | 27.80M |
| June 30, 2022 | 39.47M |
| Date | Value |
|---|---|
| March 31, 2022 | 43.58M |
| December 31, 2021 | 46.58M |
| September 30, 2021 | 45.68M |
| June 30, 2021 | 38.65M |
| March 31, 2021 | 35.08M |
| December 31, 2020 | 31.16M |
| September 30, 2020 | 30.00M |
| June 30, 2020 | 25.26M |
| March 31, 2020 | 21.87M |
| December 31, 2019 | 19.34M |
| September 30, 2019 | 14.08M |
| June 30, 2019 | 13.84M |
| March 31, 2019 | 14.24M |
| December 31, 2018 | 14.12M |
| September 30, 2018 | 14.28M |
| June 30, 2018 | 13.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tenax Therapeutics, Inc. | 45.26M |
| Manhattan Scientifics, Inc. | -- |
| Century Therapeutics, Inc. | 66.62M |
| Absci Corp. | 86.49M |
| Celularity, Inc. | 9.222M |